Verdora Excellence Alliance reviews selected companies through business development, industry conditions, and broader market environments.
Each weekly selection focuses on understanding the factors behind company development, including business models, industry trends, and market context.
VEA’s weekly selection process focuses on structured company observation, combining multiple perspectives to understand how businesses develop within changing environments. The research approach considers company information, industry conditions, market factors, and long-term development perspectives to provide a broader understanding of selected topics.
Each selection is reviewed through different research perspectives, including:
Understanding business models, operational structure, and company development direction.
Examining sector trends, competitive conditions, and industry changes.
Considering broader economic factors and external conditions influencing business development.
Applying structured methods to organize information and compare different perspectives.
Research Focus
Company, industry, and market perspectives are combined to develop a clearer understanding of selected businesses.
Market Insights
Weekly selections provide broader perspectives on business development, industry trends, and changing market environments.
Many people’s first impression of PBF Energy is often very simple: “A refining stock. It rises when oil prices rise and falls when oil prices fall.” However, this is a common misunderstanding of refining companies. PBF is not an upstream oil producer. It does not make money by: “Extracting a certain number of barrels of crude oil from the ground.” What it ac
Many people’s first impression of Amgen is: “A long-established large biotechnology company.” Unlike Moderna, it does not have an mRNA-focused growth story. Unlike smaller biotechnology companies, where one Phase 3 result can dramatically change the company’s valuation. But this is exactly where AMGN is often underestimated. Amgen’s real strength is not: Bet
When many people look at Moderna today, their first reaction is still: “The COVID vaccine company.” And this has been one of Moderna’s biggest challenges over the past few years. During the pandemic, the company generated significant revenue from its COVID vaccine. However, after the peak of the pandemic passed, COVID vaccine demand declined, and Moderna’s r
When many people look at RingCentral, their first reaction may be: “Enterprise phone software.” Those more familiar with the company understand that: It is a cloud communications SaaS company. Businesses pay a monthly subscription fee and use RingCentral for: Voice calls, messaging, video meetings, team collaboration, and contact center solutions. This under
When many people think about Meta, their first reaction is still: Facebook, Instagram, and WhatsApp. The natural assumption is that the company mainly operates through: Users consuming content → Platforms displaying advertisements → Meta generating advertising revenue. This understanding is not wrong. However, by September 2026, continuing to view META simpl
When people talk about NVIDIA today, the first association is often very simple: AI = GPU = NVIDIA. However, by August 2026, continuing to view NVDA simply as: “A company that sells GPUs” would significantly underestimate what the company is building. NVIDIA’s strategic position has expanded far beyond individual AI chips. The company is increasingly moving